Photobiomodulation for the Treatment of Diabetic Macular Edema

NCT02457975 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DEVICE: 670nm PBM
DRUG: intravitreous VEGF-inhibitors

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]